Literature DB >> 23961374

Alteration of non-protein respiratory quotient after hepatocellular carcinoma treatment can be related to des-γ-carboxy prothrombin before treatment.

Masaya Saito1, Yasushi Seo, Yoshihiko Yano, Akira Miki, Kenji Momose, Hirotaka Hirano, Masaru Yoshida, Takeshi Azuma.   

Abstract

BACKGROUND: Transcatheter arterial chemoembolization (TACE) is an effective treatment for hepatocellular carcinoma (HCC) that would occasionally lead to energy malnutrition through therapeutic hypoxic stress. We aimed to clarify the correlation between the energy malnutrition after TACE and low tolerability for hypoxia of non-tumoral liver before TACE.
FINDINGS: We performed a prospective cohort study involving 100 HCC patients who underwent TACE at Kobe University Hospital. Indirect calorimetry was performed before and 7 days after TACE, and non-protein respiratory quotient (npRQ) as an indicator of the energy malnutrition was measured. Blood biochemical examinations were also performed before TACE. As an indicator of hypoxic marker, des-γ-carboxy prothrombin (DCP) was measured before TACE. The correlation between npRQ ratio (7 days after/before TACE) and DCP (before TACE) was statistically examined. Spearman's correlation coefficient test showed that npRQ ratio (Day 7/Day 0) was significantly related to DCP (Day 0) (p=0.0481, r=-0.2033). On the other hand, npRQ ratio (Day 7/Day 0) was not related to alpha fetoprotein (Day 0) (p=0.6254, r=-0.0494).
CONCLUSIONS: The npRQ reduction after TACE was related to a high value of DCP before TACE. The energy malnutrition after TACE would originate from low tolerability for hypoxia of non-tumoral liver. The HCC patients with a high value of DCP before TACE would clinically have a high risk of the energy malnutrition after TACE.

Entities:  

Keywords:  Des-γ-carboxy prothrombin; Energy malnutrition; Hepatocellular carcinoma; Hypoxic stress; Indirect calorimetry; Non-protein respiratory quotient; Transcatheter arterial chemoembolization

Year:  2012        PMID: 23961374      PMCID: PMC3725920          DOI: 10.1186/2193-1801-1-55

Source DB:  PubMed          Journal:  Springerplus        ISSN: 2193-1801


Findings

Transcatheter arterial chemoembolization (TACE) is an effective treatment for hepatocellular carcinoma (HCC) that can deteriorate liver function. The long-term deterioration of liver function after TACE can originate from the progression of energy malnutrition (Saito et al. 2012a). In general, the non-protein respiratory quotient (npRQ) is the main factor used to evaluate energy metabolism on the basis of indirect calorimetry (Tajika et al. 2002). Short-term reduction in npRQ was found to be related to long-term liver dysfunction after TACE (Saito et al. 2012a). On the other hand, no background characteristic factors that could promote the development of energy malnutrition after TACE have been identified. We aimed to clarify the background factors related to npRQ reduction after TACE. We performed a prospective cohort study on a total of 100 patients (mean age: 70.9 years, range: 41-87 years; male:female ratio: 61:39) who underwent TACE for HCC. All patients were Japanese and had liver cirrhosis. Overall, 58 patients were classified into Child’s grade A and 42 were classified into grade B. The etiology of cirrhosis was as follows: hepatitis B in 12 patients, hepatitis C in 71, alcoholic liver dysfunction in 28, primary biliary cirrhosis in 2, autoimmune hepatitis in 2, non-alcoholic fatty liver disease in 5, and unknown in 1, although each category overlaps with others. Blood biochemical examinations were performed before TACE and indirect calorimetry was performed before and 7 days after TACE. The therapeutic volume was calculated from the distribution of Lipiodol deposits on a liver CT scan after TACE. The relationship between two variables was investigated by Spearman’s correlation coefficient test. Logarithmic transformation was performed only when variables displayed skewed distributions. Spearman’s correlation coefficient test showed that npRQ ratio (Day 7/Day 0) was significantly related to des-γ-carboxy prothrombin (DCP) (Day 0) (Figure 1: p=0.0481, r=-0.2033). The npRQ ratio was not related to any other blood biochemical factors (Day 0) (platelets, lymphocytes, aspartate aminotransferase, alanine aminotransferase, γ-glutamyltranspeptidase, total bilirubin, cholinesterase, albumin, prealbumin, branched-chain amino acid/tyrosine ratio, C-reactive protein, glucose, insulin, HOMA-IR, hemoglobin A1c, indocyanine green test retention rate at 15 min, type 4 collagen 7S, hyaluronic acid, and alpha fetoprotein) or the therapeutic volume (p>0.05). In addition, the npRQ ratio was not also related to alpha fetoprotein (Day 0) (p=0.6254, r=-0.0494).
Figure 1

The correlation between non-protein respiratory quotient (npRQ) ratio (Day 7/Day 0) and des-γ-carboxy prothrombin (DCP) (Day 0) in hepatocellular carcinoma (HCC) patients undergoing transcatheter arterial chemoembolization (TACE). The npRQ ratio (Day 7/Day 0) was significantly related to des-γ-carboxy prothrombin (DCP) (Day 0) in HCC patients undergoing TACE by Pearson’s correlation coefficient test (p=0.0481, r=-0.2033).

The correlation between non-protein respiratory quotient (npRQ) ratio (Day 7/Day 0) and des-γ-carboxy prothrombin (DCP) (Day 0) in hepatocellular carcinoma (HCC) patients undergoing transcatheter arterial chemoembolization (TACE). The npRQ ratio (Day 7/Day 0) was significantly related to des-γ-carboxy prothrombin (DCP) (Day 0) in HCC patients undergoing TACE by Pearson’s correlation coefficient test (p=0.0481, r=-0.2033). In general, DCP is an HCC tumor marker (Liebman et al. 1984). In this study, DCP was significantly related to the TNM stage and BCLC stage of HCC (p=0.0072 and 0.0001, respectively). On the other hand, DCP production is stimulated by hypoxia in human samples (Murata et al. 2010). Liver cirrhosis is associated with a state of hypoxia (Le Couteur et al. 1999). In liver cirrhosis, the increased resistance to blood flow and oxygen delivery due to an organized basement membrane results in hypoxia (Le Couteur et al. 1999). A recent study showed that serum DCP level was raised in cirrhotic patients without HCC, especially among liver transplant candidates (Yamashiki et al. 2011). Our previous study also showed that HCC patients against a background of liver cirrhosis with a high level of DCP before TACE would become sensitive to hypoxia, and that the tolerability for hypoxia of non-tumoral liver after TACE would decrease (Saito et al. 2012b). In addition, a previous study showed that the severe hypoxic state in the liver parenchyma would influence the decrease of npRQ (Mimura & Furuya 1995). In this study, npRQ reduction after TACE was not affected by the treated size of HCC (p>0.05). It was suggested that cancer cells did not play any positively supportive roles of energy metabolism. Therefore, it was suggested that the HCC patients against a background of cirrhosis with a severe hypoxic state would easily develop npRQ reduction after TACE. In conclusion, npRQ reduction after TACE was related to a high value of DCP before TACE. The energy malnutrition after TACE would originate from low tolerability for hypoxia of non-tumoral liver. The HCC patients with a high value of DCP before TACE would clinically have a high risk of the energy malnutrition after TACE.
  8 in total

1.  Prognostic value of energy metabolism in patients with viral liver cirrhosis.

Authors:  Masahiro Tajika; Masahiko Kato; Hiromi Mohri; Yoshiyuki Miwa; Tomohiro Kato; Hiroo Ohnishi; Hisataka Moriwaki
Journal:  Nutrition       Date:  2002-03       Impact factor: 4.008

2.  A high value of serum des-γ-carboxy prothrombin before hepatocellular carcinoma treatment can be associated with long-term liver dysfunction after treatment.

Authors:  Masaya Saito; Yasushi Seo; Yoshihiko Yano; Akira Miki; Masaru Yoshida; Takeshi Azuma
Journal:  J Gastroenterol       Date:  2012-03-24       Impact factor: 7.527

3.  Diagnostic accuracy of α-fetoprotein and des-γ-carboxy prothrombin in screening for hepatocellular carcinoma in liver transplant candidates.

Authors:  Noriyo Yamashiki; Yasuhiko Sugawara; Sumihito Tamura; Junichi Kaneko; Haruhiko Yoshida; Taku Aoki; Kiyoshi Hasegawa; Masaaki Akahane; Kuni Ohtomo; Masashi Fukayama; Kazuhiko Koike; Norihiro Kokudo
Journal:  Hepatol Res       Date:  2011-09-15       Impact factor: 4.288

4.  Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.

Authors:  D G Le Couteur; H Hickey; P J Harvey; J Gready; A J McLean
Journal:  J Pharmacol Exp Ther       Date:  1999-06       Impact factor: 4.030

5.  Short-term reductions in non-protein respiratory quotient and prealbumin can be associated with the long-term deterioration of liver function after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.

Authors:  Masaya Saito; Yasushi Seo; Yoshihiko Yano; Akira Miki; Masaru Yoshida; Takeshi Azuma
Journal:  J Gastroenterol       Date:  2012-02-18       Impact factor: 7.527

6.  Hypoxia-induced des-gamma-carboxy prothrombin production in hepatocellular carcinoma.

Authors:  Kazumoto Murata; Hideto Suzuki; Hiroshi Okano; Takashi Oyamada; Yoshikazu Yasuda; Atsushi Sakamoto
Journal:  Int J Oncol       Date:  2010-01       Impact factor: 5.650

7.  Mechanisms of adaptation to hypoxia in energy metabolism in rats.

Authors:  Y Mimura; K Furuya
Journal:  J Am Coll Surg       Date:  1995-11       Impact factor: 6.113

8.  Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma.

Authors:  H A Liebman; B C Furie; M J Tong; R A Blanchard; K J Lo; S D Lee; M S Coleman; B Furie
Journal:  N Engl J Med       Date:  1984-05-31       Impact factor: 91.245

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.